Login

CHINA JO-JO DRUGSTORES, INC. 3 SEC Filings

Filed On Filing
29 Nov 2018 Form 3: Hu Wei, Chief Operating Officer

No securities owned

29 Nov 2018 Form 3: Wu Pingfan, Director

No securities owned

29 Nov 2018 Form 3: Yan Liu, Secretary

No securities owned

29 Nov 2018 Form 3: He Jiangliang, Director

No securities owned

29 Nov 2018 Form 3: Wang Caroline, Director

No securities owned

30 Jan 2017 Form 3: Hillhouse Capital Management, Ltd., 10% owner

Holds 4,840,000 shares of Common Stock, par value $0.001 per share

30 Jan 2013 Form 3: Guo Taihong, Director

No securities owned

30 Jan 2013 Form 3: Su Zhimin, Director

No securities owned

05 Aug 2011 Form 3: Zhao Ming, Chief Financial Officer

Holds 6,000 shares of Common Stock

18 Mar 2011 Form 3: Ke Yuehai, Director

No securities owned

18 Mar 2011 Form 3: Yu Xiaomeng, Director

No securities owned

18 Mar 2011 Form 3: Wu Shuizhen, Director

No securities owned

18 Mar 2011 Form 3: Zhao Bowen, Director

No securities owned

18 Mar 2010 Form 3: Serrio Marc Thomas, Director

No securities owned

27 Oct 2009 Form 3: Jin Chongan, Director

Holds 12,060,000 shares of Common Stock

27 Oct 2009 Form 3: Qi Li, Director

Holds 12,060,000 shares of Common Stock

02 Oct 2009 Form 3: Super Marvel Ltd, 10% owner and 3 others

Holds 12,060,000 shares of Common Stock

28 Sep 2009 Form 3: Tchaikovsky Bennet Price Jr, Chief Financial Officer

Holds 200,000 shares of Common Stock

05 Sep 2008 Form 3: Yinglong He John, 10% owner

Holds 1,000,000 shares of Common Stock, 0.001 par value

05 Sep 2008 Form 3: Morita John S., 10% owner

Holds 1,000,000 shares of Common Stock, 0.0001 par value

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support